Which of the following conditions is the most common complication of radioiodine treatment of Grave’s disease?
Graves' disease is an autoimmune disorder causing hyperthyroidism. Radioiodine (I-131) treatment works by destroying thyroid follicular cells, which reduces hormone production. The most common complication I remember is hypothyroidism. That makes sense because destroying too many thyroid cells would lead to underactivity.
Now, why is hypothyroidism the correct answer? Radioiodine damages the thyroid gland over time, leading to decreased hormone production. The body can't compensate, so it becomes underactive. Other complications might include transient hyperthyroidism from releasing stored hormones, but hypothyroidism is more common long-term.
The wrong options could be things like thyroid storm, malignancy, or hyperthyroidism. Thyroid storm is acute and rare, not a common complication. Malignancy from radioiodine is debated but not the most frequent. Hyperthyroidism might be temporary as a side effect but not the main issue.
Clinical pearl: Remember that radioiodine treatment often leads to hypothyroidism, requiring lifelong thyroid hormone replacement. This is a key point for exams. So the correct answer is the option stating hypothyroidism.
**Core Concept**
Radioiodine (I-131) treatment for Graves' disease carries a risk of hypothyroidism due to destruction of thyroid follicular cells. The thyroid gland has a limited reserve, and excessive ablation leads to insufficient hormone production.
**Why the Correct Answer is Right**
Hypothyroidism occurs in 50–80% of patients after radioiodine therapy because the treatment irreversibly damages thyroid tissue. Over time, the gland loses its ability to synthesize thyroid hormones (T3 and T4), necessitating lifelong levothyroxine replacement. This is the most frequent complication compared to others like radiation-induced thyroiditis or malignancy.
**Why Each Wrong Option is Incorrect**
**Option A:** *Thyroid storm* is a rare, acute complication of untreated or inadequately treated hyperthyroidism, not a common outcome of radioiodine therapy.
**Option B:** *Hyperthyroidism* may transiently worsen initially due to release of stored hormones but resolves as the gland is destroyed.
**Option D:** *Thyroid malignancy* is not a recognized complication of radioiodine; in fact, its use is contraindicated in suspected thyroid cancer.
**Clinical Pearl / High-Yield Fact**
Radioiodine therapy is a definitive treatment for Graves' disease but almost always leads to hypothyroidism. Monitor TSH/T4 levels 3–6 months post-treatment and initiate levothyroxine if TSH is elevated.
**Correct Answer: C. Hypothyroidism**